WebOPAL is an australia trademark and brand of Opal Rheumatology Limited, VIC 3220,AUSTRALIA. This trademark was filed to IP Australia on Monday, March 7, 2024. ... By Opal Rheumatology Limited: The OPAL trademark was assigned an Application Number # 2254227 by the Australia Intellectual Property Office ... Web9 de ago. de 2024 · This study uses the same cohort from the Optimizing Patient outcome in Australian rheumatoLogy (OPAL) dataset to provide real-world evidence regarding clinical effectiveness, and treatment persistence among patients with RA being treated with monotherapy or combination therapy tofacitinib or bDMARDs. Methods Study design and …
The Lancet Rheumatology - Tofacitinib as monotherapy …
http://www.auscompanies.com/en/43603449154/OPAL-RHEUMATOLOGY-LIMITED WebOPAL GROUP LONDON LIMITED. Company number 10284052. Follow this company File for this company. Overview. Filing history. People. More. Registered office address. … sohn auction hibid
Using big data from real-world Australian rheumatology ... - PubMed
WebThe company registered for GST on 2015-02-03. The information on Opal Rheumatology Limited was extracted from the Australian Business Register on 31-07-2024. The ABR database was last updated on 2024-08-02. Web26 de nov. de 2024 · Introduction Sleep disturbance and fatigue are commonly reported in ankylosing spondylitis (AS) but specific prevalence and the relationship to disease control are unknown. Method This retrospective non-interventional observational study of data from the OPAL dataset included patients with AS (ICD code M45, M45.0 or M08.1), aged 18 … WebOPAL with trademark number 1366212 was lodged on 10/06/2010 and has a status of Registered/Protected. The applicant/owner of the trademark is registered as OPAL RHEUMATOLOGY LIMITED (ACN: 603449154). sohn attorneys